Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients
Open Access
- 15 May 2005
- journal article
- Published by American Society of Hematology in Blood
- Vol. 105 (10) , 4060-4069
- https://doi.org/10.1182/blood-2004-09-3704
Abstract
Multiple myeloma (MM) is a B-lineage malignancy characterized by diverse genetic subtypes and clinical outcomes. The recurrent immunoglobulin heavy cKeywords
This publication has 49 references indexed in Scilit:
- Chromatin Targeting of de Novo DNA Methyltransferases by the PWWP DomainJournal of Biological Chemistry, 2004
- Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16·3;q32) in multiple myelomaBritish Journal of Haematology, 2004
- Translocation t(11;14) in multiple myeloma: Analysis of translocation breakpoints on der(11) and der(14) chromosomes suggests complex molecular mechanisms of recombinationGenes, Chromosomes and Cancer, 2003
- Clinical and biologic implications of recurrent genomic aberrations in myelomaBlood, 2003
- A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains anIGH/MMSET fusion transcriptBlood, 2003
- Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanismOncogene, 2003
- In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expressionBlood, 2003
- The PWWP domain of mammalian DNA methyltransferase Dnmt3b defines a new family of DNA-binding foldsNature Structural & Molecular Biology, 2002
- Clinical spectrum of fibroblast growth factor receptor mutationsHuman Mutation, 1999
- Comparative Analysis of a Novel Gene from the Wolf–Hirschhorn/Pitt–Rogers–Danks Syndrome Critical RegionGenomics, 1999